A prion molecular descriptors in QSAR: a case of HIV-1 protease inhibitors. I. The chemometric approach

被引:31
|
作者
Kiralj, R [1 ]
Ferreira, MMC [1 ]
机构
[1] Univ Estadual Campinas, Inst Quim, BR-13083970 Campinas, SP, Brazil
来源
关键词
a priori molecular descriptors; QSAR; HIV-1 protease inhibitors; chemometrics;
D O I
10.1016/S1093-3263(02)00201-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A quantitative structure-activity relationship (QSAR) study on 48 peptidic HIV-1 protease inhibitors was performed. Fourteen a priori molecular descriptors were used to build QSAR models. Hierarchical cluster analysis (HCA), principal component analysis (PCA) and partial least squares (PLS) regression were employed. PLS models with 32/16 (model I) and 48/0 (model II) molecules in the training/external validation set were constructed. The a priori molecular descriptors were related to two energetic variables using PLS. HCA and PCA on data from model II classified the inhibitors as slightly, moderately and highly active; three principal components, the chemical nature of which has been highlighted, are enough to describe the enzyme-inhibitor binding. Model I (r(2) = 0.91, q(2) = 0.84) is comparable to literature models obtained by various QSAR softwares, which justified the use of a priori descriptors. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:435 / 448
页数:14
相关论文
共 50 条
  • [1] QSAR studies of HIV-1 protease inhibitors.
    Garg, R
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U908 - U908
  • [2] A priori molecular descriptors in QSAR: a case of HIV-1 protease inhibitors II. Molecular graphics and modeling
    Kiralj, R
    Ferreira, MMC
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2003, 21 (06): : 499 - 515
  • [3] Molecular modeling of HIV-1 protease inhibitors.
    Castillo, H
    Parish, C
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U298 - U298
  • [4] Comparative QSAR as a cheminformatics tool in the design of HIV-1 protease inhibitors.
    Garg, R
    Bhhatarai, B
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U778 - U779
  • [5] Determining the molecular flexibility of HIV-1 protease inhibitors.
    Parish, C
    Sinclair, K
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U602 - U602
  • [6] Chemometric classification of HIV-1 protease inhibitors
    Figueiredo, LJO
    Antunes, OAC
    [J]. INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY, 2000, 76 (06) : 744 - 755
  • [7] 3D-QSAR of cyclic urea derivatives as HIV-1 protease inhibitors.
    Debnath, AK
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U682 - U682
  • [8] QSAR Studies on HIV-1 Protease Inhibitors Using Non-Linearly Transformed Descriptors
    Saranya, Nallusamy
    Selvaraj, Samuel
    [J]. CURRENT COMPUTER-AIDED DRUG DESIGN, 2012, 8 (01) : 10 - 49
  • [9] HIV-1 protease inhibitors: A comparative QSAR analysis
    Kurup, A
    Mekapati, SB
    Garg, R
    Hansch, C
    [J]. CURRENT MEDICINAL CHEMISTRY, 2003, 10 (17) : 1679 - 1688
  • [10] CRYSTALLIZATION OF HIV-1 PROTEASE IN THE COMPLEX WITH PEPTIDOMIMETIC INHIBITORS.
    Jerabkova, H.
    Hasek, J.
    Brynda, J.
    Hradilek, M.
    [J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1999, 55 : 317 - 317